India's out-of-pocket health expenditure remains among the world's highest at roughly 47% of total health spending, according to WHO and NITI Aayog data, despite the country producing 20% of the world's generic medicines. Structural underinvestment in public healthcare, thin insurance penetration, and uncapped private-sector pricing keep an estimated 55 million Indians falling into poverty annually due to medical bills.

Here is the arithmetic that should embarrass a superpower-in-waiting: India produces one in every five generic pills consumed on Earth. Its pharmaceutical exports crossed $27.9 billion in FY2024-25, according to the Pharmaceuticals Export Promotion Council of India. Yet at home, a single hospitalisation can annihilate a family's savings — and routinely does, for 55 million people every year, per estimates cited by the Public Health Foundation of India drawing on WHO methodology.

That is not a paradox. It is a policy choice. And understanding the machinery behind it is the kind of health literacy — VidhyaKiVaidhyam, knowledge as medicine — that no prescription can replace.

The Number That Defines Indian Healthcare

Out-of-pocket expenditure (OOPE) — the share of health costs a patient pays directly from their wallet, with no reimbursement — stands at approximately 47.1% of India's total health expenditure, according to the National Health Accounts estimates for 2021-22 published by the Ministry of Health and Family Welfare. The global average, per the WHO Global Health Expenditure Database, is closer to 18%. The United States, routinely criticised for its own healthcare costs, sits at roughly 11%. Thailand — a country with a fraction of India's GDP — brought its OOPE down to under 11% through a universal coverage scheme launched in 2002, as documented by the WHO.

What makes India's number devastating is not its size alone but what it means in lived consequence. The Lancet published a 2018 analysis estimating that 17.5% of Indian households — roughly one in six — faced catastrophic health expenditure (spending more than 10% of household consumption on health). A National Sample Survey Organisation study found that medical expenses were the single largest driver of rural indebtedness, ahead of even agricultural debt. Disease, in India, is a financial event before it is a clinical one.

Why the World's Pharmacy Cannot Heal Itself

Three structural failures converge to keep this trap locked.

First, the public spending gap. India's government health expenditure hovers around 2.1% of GDP, according to the Economic Survey 2024-25. The National Health Policy 2017 committed to raising this to 2.5% by 2025 — a target that itself was considered conservative by global standards — and even that modest goal remains unmet. By comparison, Sri Lanka spends roughly 3.8% and Brazil approximately 3.9%, per World Bank data. The consequence is stark: public hospitals and primary health centres remain chronically understaffed, under-equipped, and overcrowded, pushing patients into the private sector where costs are uncapped.

Second, the insurance illusion. Ayushman Bharat — Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), launched in 2018 — was billed as the world's largest government-funded health insurance scheme, covering hospitalisation costs up to ₹5 lakh per family for roughly 55 crore beneficiaries. By the government's own data, over 34 crore Ayushman cards had been issued by early 2026. But the scheme covers only inpatient hospitalisation. Outpatient care — the doctor visit, the diagnostic test, the monthly medicines for diabetes or hypertension — accounts for the bulk of household health spending and remains almost entirely uncovered. The National Health Accounts data confirms that outpatient spending constitutes nearly 52% of total OOPE. Ayushman Bharat, for all its political heft, addresses barely half the problem.

Third, the unregulated private sector. Private healthcare facilities deliver roughly 74% of outpatient care and 65% of hospitalisation in India, according to National Sample Survey data cited by NITI Aayog. Yet price regulation remains fragmented. The Clinical Establishments (Registration and Regulation) Act, 2010, has been adopted by fewer than 15 states and union territories. Standard treatment guidelines with rate caps exist in some states but enforcement is inconsistent. The result: a diagnostic MRI can cost ₹2,000 at one centre and ₹12,000 at another in the same city, with no transparency obligation. India Herald's read of the deeper structural failure is this — the country built a globally competitive pharmaceutical export machine but never built the domestic delivery architecture to match, leaving citizens stranded between a world-class factory and a missing last mile.

The Hidden Tax on the Poor

The cruelty of high OOPE is that it is regressive — it hits the poorest hardest. A Lancet Global Health study found that the poorest quintile of Indian households spent a higher share of their income on health than the richest, despite consuming far less healthcare. The mechanism is grimly simple: wealthier families have employer insurance, private policies, or the savings to absorb a hospital bill. For a daily-wage worker earning ₹400 a day, a ₹30,000 hospitalisation is not a setback — it is a descent into debt bondage. According to Oxfam India's Inequality Report 2024, citing government survey data, nearly 63 million Indians are pushed into poverty every year by health expenses alone. That is roughly the population of France, falling below the poverty line annually because someone in the family got sick.

What Would Actually Fix This?

The prescription is known, if politically inconvenient. Health economists at the WHO and the Indian Institute of Public Health have consistently pointed to three levers:

Raise public health spending to at least 3% of GDP — not as a distant aspiration but as a time-bound fiscal commitment, ring-fenced from annual budget politics. Every percentage point of GDP directed to health spending reduces OOPE by roughly 5-7 percentage points, per cross-country WHO analysis.

Extend insurance to outpatient care. AB-PMJAY's hospitalisation-only model was a political masterstroke but an epidemiological half-measure. The diseases bankrupting Indian families are increasingly chronic — diabetes, hypertension, chronic kidney disease — requiring daily medicines and regular monitoring, not occasional hospitalisation. Without outpatient coverage, insurance is a safety net with a hole in the middle.

Regulate private healthcare pricing with teeth. Not price controls that strangle the sector, but mandatory rate transparency, standardised billing, and enforceable rate bands for common procedures and diagnostics — the kind of framework that states like Kerala and Tamil Nadu have partially implemented and that the Clinical Establishments Act was designed to enable nationally.

None of this is revolutionary. Thailand, Rwanda, and Bangladesh — countries with fewer resources — have all driven OOPE below 20% through determined public investment and coverage expansion. The knowledge exists. The fiscal space, in an economy now crossing $4 trillion, exists. What remains in question is the political will to prioritise the patient over the quarterly GDP headline — and whether India's voters will start demanding healthcare as fiercely as they demand highways.

That, in the end, is the truest VidhyaKiVaidhyam: the understanding that health literacy is not about knowing which supplement to take. It is about knowing what your government owes you — and what it costs when it does not pay up.

Reported and written with AI assistance under India Herald's editorial standards; a human editor governs publication.

Key Takeaways

• India's out-of-pocket health expenditure stands at roughly 47% of total health spending — more than double the global average of 18%, per WHO and National Health Accounts data.
• An estimated 55-63 million Indians are pushed below the poverty line every year by medical costs, per Oxfam India and Public Health Foundation of India estimates drawing on WHO methodology.
• Ayushman Bharat covers hospitalisation but not outpatient care, which constitutes 52% of out-of-pocket spending — leaving the majority of household health costs unaddressed.
• India's government health expenditure at ~2.1% of GDP remains well below the National Health Policy 2017 target of 2.5% and far from the WHO-recommended 5%.
• Private facilities deliver 74% of outpatient care with minimal price regulation, creating extreme cost variation and zero transparency for patients.